Enterprise HL7 / FHIR Terminology Engine

Universal Clinical Codes & Terminology Search

Search, verify, and inspect standardized LOINC, SNOMED CT, ICD-10-CM, RxNorm, and CPT clinical codes with native HL7 FHIR R4 resource mappings.

/
Showing 20 of 80174 codes
Per page:
Need to map or validate codes in bulk?
Cross-reference up to 1,000 ICD-10, LOINC, and CPT records simultaneously in memory with our free utility.
Open Bulk Crosswalk Tool →
Code Value Display Description Code System & OID FHIR Resource Category Status Actions
XW01318
Introduction of Daratumumab and Hyaluronidase-fihj into Subcutaneous Tissue Percutaneous Approach New Technology Group 8
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW01329
Introduction of Talquetamab Antineoplastic into Subcutaneous Tissue Percutaneous Approach New Technology Group 9
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW01348
Introduction of Teclistamab Antineoplastic into Subcutaneous Tissue Percutaneous Approach New Technology Group 8
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW0134C
Introduction of Elamipretide into Subcutaneous Tissue Percutaneous Approach New Technology Group 12
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW0136A
Introduction of Dasiglucagon into Subcutaneous Tissue Percutaneous Approach New Technology Group 10
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW013F5
Introduction of Other New Technology Therapeutic Substance into Subcutaneous Tissue Percutaneous Approach New Technology Group 5
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW013G6
Introduction of REGN-COV2 Monoclonal Antibody into Subcutaneous Tissue Percutaneous Approach New Technology Group 6
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW013H6
Introduction of Other New Technology Monoclonal Antibody into Subcutaneous Tissue Percutaneous Approach New Technology Group 6
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW013K6
Introduction of Leronlimab Monoclonal Antibody into Subcutaneous Tissue Percutaneous Approach New Technology Group 6
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW013L9
Introduction of Elranatamab Antineoplastic into Subcutaneous Tissue Percutaneous Approach New Technology Group 9
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW013S6
Introduction of COVID-19 Vaccine Dose 1 into Subcutaneous Tissue Percutaneous Approach New Technology Group 6
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW013S9
Introduction of Epcoritamab Monoclonal Antibody into Subcutaneous Tissue Percutaneous Approach New Technology Group 9
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW013T6
Introduction of COVID-19 Vaccine Dose 2 into Subcutaneous Tissue Percutaneous Approach New Technology Group 6
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW013TB
Introduction of Rozanolixizumab-noli Monoclonal Antibody into Subcutaneous Tissue Percutaneous Approach New Technology Group 11
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW013U6
Introduction of COVID-19 Vaccine into Subcutaneous Tissue Percutaneous Approach New Technology Group 6
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW013V7
Introduction of COVID-19 Vaccine Dose 3 into Subcutaneous Tissue Percutaneous Approach New Technology Group 7
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW013W5
Introduction of Caplacizumab into Subcutaneous Tissue Percutaneous Approach New Technology Group 5
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW013W7
Introduction of COVID-19 Vaccine Booster into Subcutaneous Tissue Percutaneous Approach New Technology Group 7
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW020D8
Introduction of Engineered Allogeneic Thymus Tissue into Muscle Open Approach New Technology Group 8
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
XW023S6
Introduction of COVID-19 Vaccine Dose 1 into Muscle Percutaneous Approach New Technology Group 6
 ICD-10-PCS
2.16.840.1.113883.6.4
Procedures Procedures Active
Page 3998 of 4009
Healthcare Terminology & FHIR R4 Interoperability
Standardized coding guidelines governed by CodesForMD

In HL7 FHIR R4, discrete clinical findings and laboratory measurements are encapsulated inside Observation resources. Diagnostic terms and problem list entries are represented within Condition resources, while surgical and therapeutic acts map to Procedure. CodesForMD adheres to official US Core and International FHIR Implementation Guides.

An OID is an internationally standardized dotted-decimal identifier (e.g. 2.16.840.1.113883.6.1 for LOINC) registered with HL7 and ISO. OIDs ensure unambiguous identification of terminology authorities when exchanging clinical messages across heterogeneous EHR, LIS, and PACS systems.

Yes. You can visit our platform's administrative ingestion and export engine or contact our team to obtain batch files of standardized codes.
Copied to clipboard!